The Oncosearch | Oncotarget

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Correction

Aaditya Khatri, Jing Jin Gu, Courtney M. McKernan, Xia Xu, Ann Marie Pendergast

Published Oct 3, 2019 · Vol. 10, No. 57 · pp. 6045-6046

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma Research Paper

Kwang Woon Kim, Julia Y. Kim, Jingbo Qiao, Rachael A. Clark, Camille M. Powers, Hernan Correa, Dai H. Chung

Published Sep 24, 2019 · Vol. 10, No. 54 · pp. 5645-5659

Keywords: chemotherapy, radiotherapy, resistance, AKT2, MAPK

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma Research Paper

Kwang Woon Kim, Julia Y. Kim, Jingbo Qiao, Rachael A. Clark, Camille M. Powers, Hernan Correa, Dai H. Chung

Published Sep 5, 2019

Keywords: chemotherapy, radiotherapy, resistance, AKT2, MAPK

Preliminary observations on soluble programmed cell death protein-1 as a prognostic and predictive biomarker in patients with metastatic melanoma treated with patient-specific autologous vaccines Research Paper

Robert O. Dillman, Gabriel I. Nistor, Bryce T. McLelland, Candace Hsieh, Aleksandra J. Poole, Andrew N. Cornforth, Hans S. Keirstead

Published Sep 3, 2019 · Vol. 10, No. 51 · pp. 5359-5371

Keywords: programmed cell death protein -1 (PD-1), dendritic cell vaccines, metastatic melanoma

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma Research Paper

Jennifer Bryant, Nikolaos Batis, Anna Clara Franke, Gabriella Clancey, Margaret Hartley, Gordon Ryan, Jill Brooks, Andrew D. Southam, Nicholas Barnes, Joanna Parish, Sally Roberts, Farhat Khanim, Rachel Spruce, Hisham Mehanna

Published Aug 27, 2019 · Vol. 10, No. 50 · pp. 5229-5244

Keywords: head and neck cancer, drug repurposing, drug repositioning, quinacrine, mepacrine

Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer Research Paper

Sierra A. Colavito, James T. Platt, Matthew A. Held, Zongzhi Liu, Ryan Sokup, David F. Stern

Published Aug 6, 2019 · Vol. 10, No. 47 · pp. 4822-4839

Keywords: epithelial-mesenchymal transition, triple-negative breast cancer, targeted drug combination screen, claudin-low breast cancer, CHK1

Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair Research Paper

Hasan Mahmud, Arja ter Elst, Frank J.G. Scherpen, Tiny Meeuwsen-de Boer, Kim R. Kampen, Valérie de Haas, Victor Guryev, Maikel M. Peppelenbosch, Steven M. Kornblau, Eveline S.J.M. de Bont

Published Jul 23, 2019 · Vol. 10, No. 45 · pp. 4679-4690

Keywords: AML, leukemia, peptide microarray, DNA damage and repair, signal transduction

Effect of ASA on pituitary adenomas: is it a matter of survivin? News

Fabio Rotondo, Kalman Kovacs

Published Jun 24, 2019 · Vol. 10, No. 44 · pp. 4507-4508

Keywords: acetylsalicylic acid, cell cycle, pituitary adenoma, survivin

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer Research Paper

Sandeep Rajput, Zhanfang Guo, Shunqiang Li, Cynthia X. Ma

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3667-3680

Keywords: PI3K inhibitor, BKM120, eribulin, triple-negative breast cancer, patient-derived xenograft

Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential Research Paper

Balraj Singh, Vanessa N. Sarli, Hannah E. Kinne, Anna Shamsnia, Anthony Lucci

Published Jun 4, 2019 · Vol. 10, No. 38 · pp. 3681-3693

Keywords: cancer evolution, metabolic adaptability in cancer, inflammatory breast cancer, minimal residual disease, TET2

In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile Research Paper

Shuhei Suzuki, Masahiro Yamamoto, Keita Togashi, Tomomi Sanomachi, Asuka Sugai, Shizuka Seino, Takashi Yoshioka, Chifumi Kitanaka, Masashi Okada

Published May 28, 2019 · Vol. 10, No. 37 · pp. 3547-3558

Keywords: brexpiprazole, serotonin-dopamine activity modulator, drug repositioning, drug repurposing, survivin

Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer Research Paper

Di (Maria) Jiang, Anthony Fyles, Linh T. Nguyen, Benjamin G. Neel, Adrian Sacher, Robert Rottapel, Ben X. Wang, Pamela S. Ohashi, Srikala S. Sridhar

Published Apr 26, 2019 · Vol. 10, No. 31 · pp. 2947-2958

Keywords: radiation, immunotherapy, breast cancer, anti-CTLA-4

The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations Research Paper

Michiya Sugimori, Yumiko Hayakawa, Ryoi Tamura, Satoshi Kuroda

Published Mar 22, 2019 · Vol. 10, No. 24 · pp. 2397-2415

Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles Research Paper

Harold W. Davis, Subrahmanya D. Vallabhapurapu, Zhengtao Chu, Swarajya L. Vallabhapurapu, Robert S. Franco, Michelle Mierzwa, William Kassing, William L. Barrett, Xiaoyang Qi

Published Jan 25, 2019 · Vol. 10, No. 8 · pp. 856-868

A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature Research Paper

Anju John John Velvet, Shiv Bhutani, Stavros Papachristos, Reena Dwivedi, Michael Picton, Titus Augustine, Muir Morton

Published Jan 11, 2019 · Vol. 10, No. 4 · pp. 437-448

TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase Research Paper

Elena Brin, Katherine Wu, Eleanor Dagostino, Mario Meng-Chiang Kuo, Yudou He, Wei-Jong Shia, Li-Chang Chen, Mariusz Stempniak, Richard Hickey, Robert Almassy, Richard Showalter, James Thomson

Published Dec 11, 2018 · Vol. 9, No. 97 · pp. 36914-36928

Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells via ceramide-mediated apoptosis Research Paper

Wei Sha, Yanfei Zhou, Zhi-Qiang Ling, Guiqin Xie, Xiaowu Pang, Paul Wang, Xinbin Gu

Published Nov 20, 2018 · Vol. 9, No. 91 · pp. 36331-36343

Exosomal survivin facilitates vesicle internalization Research Paper

Amber Gonda, Janviere Kabagwira, Girish N. Senthil, Heather R. Ferguson Bennit, Jonathan W. Neidigh, Salma Khan, Nathan R. Wall

Published Oct 9, 2018 · Vol. 9, No. 79 · pp. 34919-34934

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

Tasaduq H. Wani, Sreeraj Surendran, Vishnu S. Mishra, Jaya Chaturvedi, Goutam Chowdhury, Anindita Chakrabarty

Published Sep 11, 2018 · Vol. 9, No. 71 · pp. 33589-33600

Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma Research Paper

AndrÃ© Wirries, Samir Jabari, Esther P. Jansen, Silvia Roth, Elizabeth Figueroa-JuÃ¡rez, Thaddeus T. Wissniowski, Daniel Neureiter, Eckhard Klieser, Philipp Lechler, Steffen Ruchholtz, Detlef K. Bartsch, Christoph K. Boese, Pietro Di Fazio

Published Aug 31, 2018 · Vol. 9, No. 68 · pp. 32997-33010

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Correction

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma Research Paper

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma Research Paper

Preliminary observations on soluble programmed cell death protein-1 as a prognostic and predictive biomarker in patients with metastatic melanoma treated with patient-specific autologous vaccines Research Paper

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma Research Paper

Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer Research Paper

Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair Research Paper

Effect of ASA on pituitary adenomas: is it a matter of survivin? News

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer Research Paper

Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential Research Paper

In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile Research Paper

Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer Research Paper

The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations Research Paper

Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles Research Paper

A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature Research Paper

TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase Research Paper

Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells via ceramide-mediated apoptosis Research Paper

Exosomal survivin facilitates vesicle internalization Research Paper

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation Correction

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma Research Paper

Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma Research Paper

Preliminary observations on soluble programmed cell death protein-1 as a prognostic and predictive biomarker in patients with metastatic melanoma treated with patient-specific autologous vaccines Research Paper

Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma Research Paper

Combinatorial drug screening of mammary cells with induced mesenchymal transformation to identify drug combinations for triple-negative breast cancer Research Paper

Peptide microarray of pediatric acute myeloid leukemia is related to relapse and reveals involvement of DNA damage response and repair Research Paper

Effect of ASA on pituitary adenomas: is it a matter of survivin? News

PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer Research Paper

Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential Research Paper

In vitro and in vivo anti-tumor effects of brexpiprazole, a newly-developed serotonin-dopamine activity modulator with an improved safety profile Research Paper

Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer Research Paper

The combined efficacy of OTS964 and temozolomide for reducing the size of power-law coded heterogeneous glioma stem cell populations Research Paper

Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles Research Paper

A single-center experience of post-transplant lymphomas involving the central nervous system with a review of current literature Research Paper

TRAIL stabilization and cancer cell sensitization to its pro-apoptotic activity achieved through genetic fusion with arginine deiminase Research Paper

Antitumor properties of Salvianolic acid B against triple-negative and hormone receptor-positive breast cancer cells via ceramide-mediated apoptosis Research Paper

Exosomal survivin facilitates vesicle internalization Research Paper

Adaptation to chronic exposure to sepantronium bromide (YM155), a prototypical survivin suppressant is due to persistent DNA damage-response in breast cancer cells Research Paper

Panobinostat mediated cell death: a novel therapeutic approach for osteosarcoma Research Paper